首页> 美国卫生研究院文献>Disease Markers >Mitochondrial T16189C Polymorphism Is Associated with Metabolic Syndrome in the Mexican Population
【2h】

Mitochondrial T16189C Polymorphism Is Associated with Metabolic Syndrome in the Mexican Population

机译:线粒体T16189C多态性与墨西哥人群的代谢综合症有关。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Genetic factors, such as the mitochondrial DNA (mtDNA) T16189C polymorphism, have been associated with metabolic syndrome (MetS), but this association has not been studied in Mexico to date. The aim of the present study was to determine whether this polymorphism contributes to MetS in the Mexican population. We recruited 100 unrelated volunteer subjects who were divided into 2 groups: with MetS (MetS group) and without MetS (control group). All subjects were genotyped for the mtDNA T16189C polymorphism by polymerase chain reaction and sequencing. The mitochondrial T16189C polymorphism was detected in 24 (24%) of 100 subjects analyzed. The frequency of the mtDNA T16189C polymorphism was higher in the MetS group with 21 (32.3%) of 65 testing positive compared to 3 (8.5%) of 35 in the control group, indicating that this polymorphism is a probable risk factor for MetS in the Mexican population (odds ratio 5.0909, 95% CI 1.3977–18.5424, P = 0.0136). Our results may contribute to early diagnosis of MetS, which is essential for establishing changes in early stages of the disease to avoid further complications and pathologies, thereby preventing the development of type 2 diabetes and cardiovascular disease in Mexico.
机译:遗传因素,例如线粒体DNA(mtDNA)T16189C多态性,已与代谢综合征(MetS)相关,但迄今为止尚未在墨西哥进行研究。本研究的目的是确定这种多态性是否有助于墨西哥人群中的MetS。我们招募了100名无关的志愿者受试者,将其分为2组:有MetS(MetS组)和无MetS(对照组)。通过聚合酶链反应和测序对所有受试者的mtDNA T16189C多态性进行基因分型。在分析的100位受试者中,有24位(24%)检测到线粒体T16189C多态性。 MetS组中mtDNA T16189C多态性的频率更高,其中65(21)(32.3%)呈阳性,而对照组中35(3(8.5%))呈阳性,这表明该多态性可能是MetS人群中MetS的危险因素。墨西哥人口(赔率5.0909,95%CI 1.3977-18.5424,P = 0.0136)。我们的结果可能有助于MetS的早期诊断,这对于确定疾病早期阶段的变化至关重要,以避免进一步的并发症和病理,从而防止了墨西哥2型糖尿病和心血管疾病的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号